Literature DB >> 7669660

Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype.

G Mallinson1, K S Soo, T J Schall, M Pisacka, D J Anstee.   

Abstract

The erythrocyte chemokine receptor, a receptor for Plasmodium vivax, carries the antigens of the Duffy blood group system. Sequence analysis of reticulocyte RNA from individuals of known Duffy phenotype showed that the Fya antigen differs from the Fyb antigen as a result of a single nucleotide difference (A131 or G) encoding amino acid Gly44 (Fya) or Asp (Fyb) in the N-terminal extracellular domain of the glycoprotein. Evidence is presented for two different genetic backgrounds giving rise to the Fy(a-b-) phenotype. The most likely genetic mechanism in most individuals of the Fy(a-b-) phenotype is down-regulation of Duffy glycoprotein mRNA. However, the Duffy gene from a very rare Caucasian individual (AZ) with the Fy(a-b-) phenotype has a 14 base-pair deletion (nucleotides 287-301) resulting in a frameshift which introduces a stop codon and produces a putative truncated 118 amino acid protein. The occurrence of this mutation in an apparently healthy individual raises questions about the functional importance of the Duffy glycoprotein not only in normal erythrocytes but also in all human cells and tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669660     DOI: 10.1111/j.1365-2141.1995.tb05202.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

1.  Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene.

Authors:  H Luo; A Chaudhuri; K R Johnson; K Neote; V Zbrzezna; Y He; A O Pogo
Journal:  Genome Res       Date:  1997-09       Impact factor: 9.043

Review 2.  Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1).

Authors:  B J Doranz; J F Berson; J Rucker; R W Doms
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

3.  Myelopeptide 6, a novel endogenous bone marrow-derived differentiation factor.

Authors:  E A Kirilina; A A Mikhailova; M A Efremov; R V Petrov
Journal:  Dokl Biol Sci       Date:  2008 Jul-Aug

Review 4.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

5.  Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain.

Authors:  J M Rubio; A Benito; P J Berzosa; J Roche; S Puente; M Subirats; R López-Vélez; L García; J Alvar
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  FY polymorphisms and vivax malaria in inhabitants of Amazonas State, Brazil.

Authors:  Sérgio Roberto Lopes Albuquerque; Francimary de Oliveira Cavalcante; Edalton Cesar Sanguino; Lucianna Tezza; Fernanda Chacon; Lilian Castilho; Maria Cristina dos Santos
Journal:  Parasitol Res       Date:  2010-02-17       Impact factor: 2.289

Review 7.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

8.  Duffy Blood Group System and the malaria adaptation process in humans.

Authors:  Gledson Barbosa de Carvalho; Glauber Barbosa de Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Authors:  Christophe Tournamille; Antoine Blancher; Caroline Le Van Kim; Pierre Gane; Pol André Apoil; Wilson Nakamoto; Jean Pierre Cartron; Yves Colin
Journal:  Immunogenetics       Date:  2004-01-08       Impact factor: 2.846

Review 10.  DARC and D6: silent partners in chemokine regulation?

Authors:  Chris A H Hansell; Catherine E Hurson; Robert J B Nibbs
Journal:  Immunol Cell Biol       Date:  2010-12-14       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.